Subscribe
shutterstock_1953872299_marlon_trottmann
Marlon Trottmann / Shutterstock.com
12 July 2022Americas

Swiss big pharma settles patent dispute with Insulet

The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Medtronic’s $738m deal with insulin maker at risk
12 October 2023   Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.
Americas
Judge cuts ‘disproportionate’ £1.7m costs claim by Roche
27 July 2021   Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.
Medtech
English court says Roche did not infringe insulin pump patents
13 July 2021   The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Big Pharma
Medtronic’s $738m deal with insulin maker at risk
12 October 2023   Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.
Americas
Judge cuts ‘disproportionate’ £1.7m costs claim by Roche
27 July 2021   Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.
Medtech
English court says Roche did not infringe insulin pump patents
13 July 2021   The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.

More on this story

Big Pharma
Medtronic’s $738m deal with insulin maker at risk
12 October 2023   Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.
Americas
Judge cuts ‘disproportionate’ £1.7m costs claim by Roche
27 July 2021   Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.
Medtech
English court says Roche did not infringe insulin pump patents
13 July 2021   The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB